Recruiting Pharmacokinetics of Antibiotics in Patients With Cystic Fibrosis Trated With Elexacaftor/Tezacaftor/Ivacaftor (ETI) NCT07629986 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis (CF), +8 more Locations Fondation ILDYS — Roscoff, France View Trial Details
Recruiting OLE Therapy With BE Patients in Home Care Study NCT06926881 Conditions Bronchial Diseases, Bronchiectasis, Pulmonary Exacerbation, +1 more Locations Yale School of Medicine — New Haven, Connecticut, United States Central Florida Pulmonary Group, P.A. — Orlando, Florida, United States Treasure Coast Medical Research Group, LLC — Port Saint Lucie, Florida, United States Metropolitan Clinical Research — Tamarac, Florida, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies NCT00727285 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +9 more Locations National Jewish Health — Denver, Colorado, United States View Trial Details
